chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Cough, Dyspnoea
Clinical narrative: Information has been received from an LPN concerning a 12 month old male with eggs allergy who in 1996 was vaccinated with the 1st dose of MMRII, 4 years ago. Within 24 hours, the pt experienced trouble breathing and coughing. On 9/10/01, the LPN reported the pt "just received his 2nd vaccination with MMRII, with no adverse event". No further information is available.
Sex: U
Vaccine: MMR
Symptoms: Rash morbilliform
Clinical narrative: Information has been received from a physician concerning a pt (demographics unspecified) who on 8/10/01 was vaccinated with a dose of MMRII. On 9/10/01, it was reported that "now" the pt has a "measles-like rash". The pt sought unspecified medical attention. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: MMR
Symptoms: Feeling hot, Pyrexia, Rash
Clinical narrative: Information has been received from a woman in a physician's office and a consumer concerning their 16 month old white female relative with sulfa allergy and no past medical history who on the morning of 8/27/92 was vaccinated in the deltoid with the 1st dose (lot unknown) of MMRII. During the morning of vaccination, the pt broke out in a rash over her trunk, experienced "heat" in her leg and developed a fever of 101F. The consumer was told to give the pt Tylenol and Benadryl. Unspecified medical attention was sought. Subsequently, the pt recovered within 3-4 days. No further information is available.
Age: 28.0
Sex: F
Vaccine: MMR
Symptoms: Laboratory test abnormal
Clinical narrative: Information has been received on 9/12/01 from a pharmacist concerning a 28 year old pregnant female who "many years ago" was vaccinated with a dose of MMRII. On 9/12/01, it was reported that the pt "now" has protective titers of mumps and rubella antibodies, but is sero-negative for measles antibodies. The pt was in the 3rd trimester of pregnancy. It was noted that the pt did not receive MMRII during her pregnancy. The pt sought unspecified medical attention. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Injection site swelling, Swelling, Urticaria
Clinical narrative: Information has been received from a consumer concerning a female relative with a fruit allergy (all) and a vegetable allergy (all) who in approx. 9/00 was vaccinated with a dose of MMRII. Immediately after vaccination, the pt developed swelling around the injection site. Within 20 minutes of vaccination, the pt developed swelling around different spots on her body and cluster hives. Unspecified attention was sought. No further information was provided. Additional information has been requested.
Age: 1.25
Sex: M
Vaccine: DTP, HIBV, IPV, MMR
Symptoms: Erythema, Ocular hyperaemia, Pyrexia, Rash macular, Rhinorrhoea
Clinical narrative: Information has been received from a health professional concerning a 19 month old white male pediatric pt with an ear infection at the time of vaccination, no past medical history and no known drug allergies who on 9/5/01 was vaccinated SC in his right leg with his 1st dose of MMRII (dosage not reported, lot 639918/0743L). Concomitant therapy that day, included a dose of HIB (mfr unk), DTP and poliovirus vaccine. Other concomitant therapy that day, included amoxicillin for an ear infection. On 9/12/01, the pt's cheeks were red and he had a blanching, red, macular rash on his trunk and upper extremities. There was little rash on the lower extremities. He developed conjunctival redness and rhinorrhea. The pt also had a temperature of 100.3F. The pt sought unspecified medical attention. On follow-up, the pt's physician reported that the pediatric pt had recovered. No further information was available.
Age: 21.0
Sex: F
Vaccine: MMR
Symptoms: Laboratory test abnormal
Clinical narrative: Information has been received from a health professional concerning a 21 year old female with no past medical history or allergies who in "childhood" and in 2/01 was vaccinated with the 1st and 2nd dose of MMRII, respectively. There was no concomitant therapy. In 8/01, the pt had titers drawn which revealed that the mumps titer was .97 which was considered to be equivocal. It was also reported that the pt had a lack of sero-conversion. The measles and rubella titers were positive. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: HBHEPB, MMR, VARCEL
Symptoms: Pruritus, Rash
Clinical narrative: Information has been received from an LPN concerning a 12 month old male with no known drug allergies or past medical history who on 9/18/01 (PM) was vaccinated with the 1st dose of MMRII (634429/1391K) SC in the right thigh. Concomitant therapy that same day included the 3rd dose of HIB-Hep-B vaccine (lot 639442/0483L) IM in the left thigh and the 1st dose of varicella vaccine (lot 638252/0225L) SC in the left thigh. It was reported that the vaccinations were administered at different sites. There were no other concomitant medications. There was no illness at the time of vaccination. On 9/19/01, the pt had a rash/bumps on the face, neck and chest. There was no fever or scratching. On 9/20/01, the pt was seen in the physician's office with an itchy, red rash/bumps over the entire body. The pt had scratching but was afebrile. The pt received treatment with Benadryl 1 teaspoon every 6 hours. There were no other symptoms noted. On an unknown date, the pt recovered. No further information is available.
Age: 1.2
Sex: U
Vaccine: MMR
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a woman in a physician's office concerning a 14 month old pt who on an unspecified date was vaccinated with either a dose of MMRII or a dose of rubella virus vaccine live (2nd generation). The reporter was not sure which vaccine was administered. Subsequently, the pt developed a fever and rash. The pt sought unspecified medical attention. Additional information has been requested.
Age: 1.7
Sex: F
Vaccine: MMR
Symptoms: Erythema multiforme, Pyrexia, Rash
Clinical narrative: Information has been received from a physician concerning a 20 month old female, with no medical history or known allergies, who on 5/21/01 was vaccinated with a dose of MMRII. There was no concomitant medication. On 5/31/01, 10 days later, the pt developed erythema multiforme minor, a temperature of 100F and rash which lasted several days. The physician reported that this was not a case of Stevens-Johnson syndrome. Medical attention was sought. The child was treated with Benadryl. Subsequently, the pt recovered "with no problem". Additional information has been requested.
Age: 1.0
Sex: U
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Information has been received from an LPN concerning a 12 month old pt who on 9/17/01 was vaccinated with a dose of MMRII. Five or six days, post vax, on approx. 9/22/01, the pt broke out in spots. The LPN reported that she does not know if rash was all over the body but reported that the spots/rash was starting to spread to the child's face. Unspecified medical attention was sought. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Injection site reaction, Pyrexia, Rash
Clinical narrative: Information has been received from a pharmacist concerning an adult female pt who was vaccinated with MMRII. Within 2 days, post vax, the pt developed a "local reaction" and fever. Two to three days after the fever, the pt developed a rash. Unspecified medical attention was sought. Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: HEP
Symptoms: Convulsion, Dizziness, Pallor, Syncope
Clinical narrative: Client was dizzy, fainted, pale. Client also had what appeared to be seizure type activity. Administered 0.4 epi SQ R post arm. Monitored vitals.
Age: 0.5
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV
Symptoms: Erythema, Pyrexia, Rash, Somnolence
Clinical narrative: Recieved shots at approximately 10 a.m. 7/13.  Was fine only sleepy.  2:00 a.m. he woke up with a fever of 102.2.  Nursed him throughout the night.  Woke up at 7 a.m. with a fever of 102.5.  Fever then gradually went down over the morning finally returning to normal.  Over the morning he started getting red bumps over his back and arms.  The next day the fever was completely gone but his bumps are spreading.  That's the current situation.
Age: 1.0
Sex: M
Vaccine: HEP
Symptoms: Drug toxicity, Nervous system disorder
Clinical narrative: Information has been received regarding a case in litigation concerning a male child who, for the first two years of his life, was vaccinated with injections containing the dangerous and highly toxic mercury based preservative thimerosal. The alleged result of these vaccinations is that the patient now suffers from, and allegedly in the future will continue to suffer from, the toxic neurological effects of mercury poisoning. Immunization records were received and reported that the patient was vaccinated with his second and third doses of hepatitis B vaccine recombinant on 18 FEB 1996 and 21 SEP 1997 and his first dose of MMR on 13 FEB 1998; a first dose of hepatitis B vaccine, recombinant on 2 DEC 1996, oral poliovirus vaccine on 2 DEC 1996, HIB conjugate vaccine on 21 APR 1997 and 13 FEB 1998; diphtheria toxoid, haemphilus B conjugate vaccine, pertussis vaccine, tetanus toxoid and alum on 02 DEC 1996; potassium, diphtheria toxoid, pertussis vaccine, tetanus toxoid given on 21 APR 1997. Upon internal review toxic neurological effect and mercury poisoning were determined to be other important medical events. No further information is available. A 15-day follow report received on 05/14/2003 adds no new info.
Age: 0.3
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Abnormal behaviour, Convulsion, Electroencephalogram abnormal, Laboratory test abnormal, Tremor
Clinical narrative: From telephone call received on 07/03/02 from health care professional it was reported on that a 4 month old female infant was vaccinated on 06/24/02 with Tripedia lot #U0548BA, Prevnar lot #484237, IPOL lot #U0823 and ActHIB lot #UA710AA. That same day in the pt experienced seizure activity consisting of body tremors, head bobbing and tongue biting. The pt had an MRI and EEG done on 06/27/2002 and was evaluated by a neurologist on 06/28/2002. Child was not hospitalized. Seizures continue. No specific medical treatment was relayed by the reporter. *F/UP report on 10/29/02: F/UP #1 correspondence: PT is still having tremors and is being followed by a neurologist. The MRI exam of the brain revealed that there is a vague 4 mm focus of increased signal intensity on coronal T1-weighted sequence at the inferior aspect of the right basal ganglia. Follow-up MRI exam is suggested. The EEG results were abnormal due to some fairly persistent intermittent but frequently recurrent asymmetric slowing over the right hemisphere, maximal over the right occipital and right mid- and posterior temporal region. No definite epileptiform discharges were seen. Correlation with clinical data is indicated. Follow up on 08/22/2003: "Despite several attempts to obtain further information for this case, no further information has been received.  The case is considered closed." Follow up on 11/25/2003: "Patient is still having tremors and is being followed by a neurologist.  The MRI examination of the brain revealed that there is a vague 4mm focus of increased signal intensity on coronal T1-wighted sequence at the inferior aspect of the right basal ganglia.  No abnormality can be seen on other sequences, and the clinical significance of this finding is uncertain.  Follow-up MRI exam is suggested.  The EEG results were abnormal due to some fairly persistent intermittent but frequently recurrent asymmetric slowing over the right hemisphere, maximal over the right occipital and right mid and posterior temporal region.  No definite epileptiform discharges were seen.  Correlation with clinical data is indicated. "
Sex: M
Vaccine: HEP
Symptoms: Drug toxicity, Laboratory test abnormal, Nervous system disorder
Clinical narrative: Information has been received from a legal firm regarding a case in litigation concerning a male child who was vaccinated with a first , second and third dose of Recombivac HB, first dose IM in the left thigh, second and third doses IM in the right thigh, 06/03/97, 02/09/98 and 08/25/98. Concomitant therapy included a dose of Varivax in the left leg on 09/08/97, a dose of MMR on 09/08/98, a first, second, third and fourth dose of Orimune on 11/18/96, 01/07/97, 04/03/97 and 12/09/97. a first and second dose of Trihibit on 11/18/96, 01/07/97, a third dose on 12/09/97 in the left thigh, a dose of Tripedia in the left thigh on 04/03/97; a dose of Hibvax on 04/03/97 in the left thigh. The alleged result of these vaccinations is that the patient suffers from and in the future will continue to suffer the toxic neurological effects of mercury poisoning. *This is an amended report. This report had been previously sent on 8/13/02 and 8/26/02 w/the incorrect date received by manufacturer of 2/4/02. The correct date received by manufacturer is 6/28/02. * Upon internal review, mercury poisoning and neurological disorders were considered to be other important medical events. (OMIC) No further information is available. This report is corrected as amended. The follow up received on 5/1/03 received from a physician indicating that an analysis for urine toxic metals on 2/17/02 showed lead 78ug/g (very elevated, N<15), mercury 1.4ug/g (n<3), and on 5/12/02 showed lead 47ug/g (N<15) and mercury 1.4ug/g (n<3). The physiican also reported that it could not be stated beyond a doubt that the pt had mercury toxicity and that there was no way that anyone could state this about anyone. No further info is available.
Sex: M
Vaccine: DTPHIB, HEP, OPV
Symptoms: Drug toxicity, Nervous system disorder
Clinical narrative: Information has been received from a legal firm regarding a case in litigation concerning a male child who was vaccinated with a first, second and third dose of hep b vaccine recombinant in the left thigh on 01/17/94, in the right thigh 03/11/94 and 07/13/94. Concomitant therapy included MMR II in the left thigh on 04/12/95; HIB conjugate vaccine in the right thigh on 04/12/95; a first, second, third and fourth dose of Tetramune vaccine in the left thigh on 03/11/94, 05/12/94, 07/13/94 and 07/07/95; a first, second, and third dose of oral poliovirus vaccine on 03/11/94, 05/12/94 and 07/13/94; a dose of purified protein derivative on 11/03/94. The alleged result of these vaccinations is that the pt suffers from and in the future will continue to suffer the toxic neurological effects of mercury poisoning. *F/UP report on 10/10/02: This is an amended report. The lot #'s have been added for Hep B vax recombinant and MMRII.* Upon internal review, toxic neurological effects and mercury poisoning were considered to be other important medical events (OMIC). No further info is available.
Sex: M
Vaccine: HEP
Symptoms: Drug toxicity, Nervous system disorder
Clinical narrative: Information has been received from a legal firm regarding a case in litigation concerning a male child who on 08/11/94 was vaccinated IM in the left thigh with a third dose of hep b vaccine recombinant. Concomitant therapy included a dose of varicella virus vaccine live SC in the left leg on 09/26/95 a dose of MMR II SC in the right thigh on 02/02/95; a first and second dose of Tetramune IM in the left thigh on 01/03/94; a dose of oral poliovirus vaccine on 01/03/94; a first dose of hep b vaccine recomb IM in the right thigh on 01/03/94; tuberculin purifiec protein derivative on 08/11/94; a first dose of HIB conjugate vaccine IM in the left thigh on 02/02/95. The alleged result of these vaccinations is that the pt suffers from and in the future will continue to suffer the toxic neurological effects of mercury poisoning. *F/UP report 10/21/02: This is an amended report. The report that had been previously sent on 8/26/02 w/the incorrect date received by manufacturer of 2/4/02. The correct date received by manufacturer is 6/28/02. The name of the primary subject therapy has been changed from Recombivax to Recombivax HB.* The US equivalent fill/lot number for MMRII vax has been added. Upon internal review, mercury poisoning and neurological disorders were considered to be other important medical events (OMIC). No further info is available.  Reported on 05/14/2003: "Follow up information received on 05/01/2003 indicated that the patient received injections of vaccines allegedly containing thimerosal on the following dates: 08/30/1993, 12/30/1993, 01/03/1994, 03/03/1997, 04/29/1994, 05/02/1994, 08/10/1994, 09/25/1995, 02/01/1995, 05/29/1998, 07/06/1999, 01/28/2000, and  03/01/2000.  Upon internal review, mercury poisoning and neurological disorders were considered to be other important medical events.  No further information is available.  A copy of the patient's complete medical records is available upon request.
Sex: M
Vaccine: DTP, HEP, HIBV, OPV
Symptoms: Drug toxicity, Nervous system disorder
Clinical narrative: Information has been received regarding a case in litigation concerning a male child who, for the first two years of his life, was vaccinated with injections containing the dangerous and highly toxic mercury based preservative thimerosal. The alleged result of these vacciantions is that the patient now suffers from, and allegedly in the future will continue to suffer from, the toxic neurological effects of mercury poisoning. Immunization records were received and indicated that the patient was vaccinated with his first and second doses of hepatitis B vaccine recombinant on 08 APR 1994 was given in the right thigh on 06 JUN 1994 and MMR vaccine live on 07 JUL 1995; a first dose of oral poliovirus vaccine on 06 JUN 1994, and 10 OCT 1994; first dose of diphtheria toxoid, pertussis vaccine, teta given on 06 JUN 1994, diphtheria toxoid, haemophilus B conjugate vaccine, pertussis vaccine tetanus toxoid on 08 AUG 1994 and 10 OCT 1994; a single dose of alum, potassium, diphterhia toxoid, pertussis vaccine, tetanus toxoid on 19 OCT 1995, HIB conjugate vaccine on 06 JUN 1994, HIB conjugate vaccine on 07 JUL 1995; a dose of hepatitis B, recomb given on 10 OCT 1994, and tuberculin purified protein derivative on 14 APR 1995, result negative. Upon internal review, toxic neurological effect and mercury poisoning were determined to be other important medical events. No further information is available. Follow up on 10/31/2003: "This is an amended report.  The primary therapy has been changed from hepatitis B virus vaccine rHBsAg (yeast) (Recombivax) to hepatitis B virus vaccine rHBsAg (yeast) (Recombivax HB).  This report is corrected as amended."
Age: 0.25
Sex: M
Vaccine: HEP, HIBV, MMR, OPV
Symptoms: Drug toxicity, Nervous system disorder
Clinical narrative: Information has been received regarding a case in litigation concerning a male child who was injected with vaccinations containing the toxic mercury-based preservative thimerosal. The alleged result of these vaccinations is that the patient suffers from and in the future will continue to suffer the toxic neurological effects of mercury poisoning. Immunization records were received and it was reported that the patient was vaccinated with his first two doses of hepatitis B vaccine recombinant (yeast) (lot# and manufacturer not reported for the dose given 16 SEP 1996; lot# 620757/1101D given in the left thigh on 12 DEC 1996, and MMR vaccine (lot #622262/0594E given subcuttaneously in the right arm), a third dose of hepatitis B vaccine, recomb (ENGERIX-B) (lot# 2292A2 given in the right thigh on 16 JUN 1997), the first through third doses of HIB conjugate vaccine (ACTHIB (Haemophilus B conjugate vaccine)) (lot #6C71070 given in the right anterior thigh on 15 NOV 1996; lot# 6A81169 given in the left anterior thigh on 17 JAN 1997; lot #6A8117 given in the left thigh on 14 MAR 1997), the fourth dose of HIB conjugate vaccine (OMNIHIB)(lot# M0293 given in the left deltoid on 12 DEC 1997), oral poliovirus vaccine (ORIMUNE) (lot#0749L6 given 15 NOV 1996; lot #0750A given 17 JAN 1997 and lot # 0772H given 20 MAR 1998), the first through third doses of alum, potassium, diphtheria toxoid, pertussis vaccine, tetanus toxoid (TRIPEDIA) (lot# 6571059 given in the right anterior thigh on 15 NOV 1996; lot # 6A81169 given in the left anterior thigh on 17 JAN 1997; lot # 6L71162 given in the left thigh on 14 MAR 1997), diphtheria toxoid/pertussis vaccine teta (INFANRIX) (lot# 833A2 given IM in the right deltoid and tuberculin purified protein derivative (PPD TINE TEST) (lot # not provided); result negative. Upon internal review, mercury poisoning and neurological disorders were considered to be other important medical events. No further information is available. Follow up info regarding a case in litigation was received included a pt's hair analysis lab results dated 9/12/97 that revealed aluminum 73.6, antimony 0.254, cadmium 0.555, lead 1.62, mercury 6.88, nickel 0.526, tin 0.739, chromium 1.36, cooper 34.2, iodine 2.78, sulfur 56.389 and zinc 217. It was noted that the pt had elevated results through a repeat analysis on 6/14/01. On 3/22/02, the pt's urine toxic metals lab results revealed mercury at 0.9ug/g. No further info is available.  A 15-day follow up report received 05/20/2003 adds: Follow up info was received that reported the pt was allegedly injected with vaccines containing thimerosal on the following date: 09/16/1996, 11/15/1996, 12/12/1996, 01/17/1997, 03/14/1997, 06/16/1997, 09/17/1997, 12/12/1997 and 03/20/1998. Upon internal review, mercury poisoning and neurological disorders were considered to be other important medical events. No further info is available. A copy of the pt's complete medical records is available upon request.
Age: 3.0
Sex: M
Vaccine: MMR
Symptoms: Antisocial behaviour, Autism, Speech disorder
Clinical narrative: Information has been received from a mother concerning her 3 year old male son with no known drug allergies and a history of cellulitis of cheek and eye five times who was vaccinated with a dose of MMR II. Subsequently at three years of age, in approximately 1997, the pt was diagnosed with autism. The mother reported that 2 other siblings received MMR II without adverse symptoms. *Follow-up report on 7/29/02: Conflicting info. has been received from an MD's assistant. The MD's assistant reported that the PT was first seen in the practice at the age of 10-11 mts, and in 98, the PT was referred for psychological counseling due to behavioral issues. In March 99, the PT was diagnosed w/a speech delay and social skill problems. In 99, the PT was diagnosed w/Asperger's Syndrom. It was reported that the PT attended a special school and was receiving speech therapy, occupational therapy (OT), and psychological counseling. The MD's assistant reported that the PT's MD felt that the PT's Asperger's Syndrom was not related to the MMRII.* Upon internal review, autism was considered an other medical event (OMIC). Additional info has been requested. The mother also reported that her other son also developed autism at 17 months old after vaccination with MMR II (WAES0207USA00696).
Age: 1.4
Sex: M
Vaccine: MMR
Symptoms: Autism, Neurodevelopmental disorder, Speech disorder
Clinical narrative: Information has been received from a mother concerning her 17 month old male son with breathing problems, an allergy to cefadroxil (DURICEF) and a history of pneumonia respiratory syncytial viral at birth and inguinal hernia repair (01 FEB 2002) who on 12/16/98 was vaccinated with a dose of MMR vaccine live. In approximately December 1998, the patient experienced symptoms of banging head on floor, hitting his face and was diagnosed with autism. The mother reported that 2 other siblings received MMRII (exact dates unknow) without adverse symptoms. Upon internal review, autism was considered an other medical event. *Follow-up report on 7/29/02: Follow-up info. has been received from an MD's assistant (PA). The PA reported that on 12/16/98, the same day as the vax, the PT was referred to a developmental center due to behavioral concerns of increased temper tantrums. At the developmental center, the PT was diagnosed with developmental delay and a speech delay. The PT attended a regular school and has attended kindergarten. The PA reported that the PT was doing well and the only extra services that he has received was occupational therapy. Upon internal review, the PT's developmental delay was considered an other important medical event.* Additional information has been requested. The mother also reported that her other son also developed autism at 3 years old after vaccination with MMR.
Age: 0.75
Sex: M
Vaccine: HEP
Symptoms: Convulsion, Mental retardation severity unspecified
Clinical narrative: Information has been received from a medical assistant concerning a 9 month old male with an allergy to amoxicillin trihydrate, clavulanate potassium who on 15 DEC 1998 was vaccinated with the third dose of hepatitis B vaccine recombinant. It was reported that the patient received the first and second dose of vaccine at birth on 10 JUN 1998 and on 10 JUL 1998 respectively. It was reported that in approximately March 1999, at 9 months of age, the patient was diagnosed with developmental delay. On 22 JUN 1999, the child received MMR. It was reported that in approximately Septermber 1999, at 15 months of age, the patient was diagnosed with seizure disorder. The patient was treated with divalproex sodium. On 17 DEC 1999, the patient received varicella virus vaccine live. The outcome of the patient's developmental delay and seizure disorder was unknown. Upon internal review, it has been determined that the patient's developmental delay and seizure disorder to be other important medical events. Additional information has been requested.   A follow up report received 7/22/2002 adds: In follow-up, the medical assistant reported on 07/08/2002 that the pt had "a possible diagnosis of autism". Upon internal review, it has been determined that the pt's developmental delay and seizure disorder to be other important medical events. Additional info has been requested.
Age: 1.0
Sex: M
Vaccine: HEP
Symptoms: Drug toxicity, Nervous system disorder
Clinical narrative: Information has been received regarding a case in liitgation concerning a male child who, for the first two years of his life, was vaccinated with injections containing then "dangerous and highly toxic" mercury based preservative Thimerosal. The alleged result of these vaccinations is that the patient now suffers from, and allegedly in the future will continue to suffer from the toxic neurological effects of mercury poisoning. Immunization records were received as FOLLOW-UP information. It was reported that the patient was vaccinated with Recombivax (lot # given not valid) given in the right anterior thigh on 11/21/96, 01/29/97 and 10/01/97. Concomitant therapy included MMR (lot # not valid), ACTHib/DTP, given in the right anterior thigh on 11/21/96 and in the left anterior thigh on 01/29/97 and 03/25/97, Tripedia, given in left deltoid on 03/31/98, Orimune , given 11/21/96, 01/29/97 and 03/25/97. ACtHib given in the left deltoid on 12/24/97. Upon internal review toxic neurological effect and mercury poisoning were determined to be other important medical events. No further information is available. A 15-day follow up report received 05/20/2003 adds: It was also noted that the pt was born via vaginal delivery at 38 weeks weighing 5lb 5oz. There were no birth complications. It was also noted that the pt's father has the thalassemia trait. Follow up info received on 05/01/2002 reported that the pt received injections of vaccines that have been alleged to contain thimerosal on the following dates: 11/21/1996, 01/29/1997, 03/25/1997, 10/01/1997, 12/24/1997, 03/31/1998/ 04/29/1999 and 10/09/2000. Upon internal review toxic neurologic effect and mercury poisoning were determined to be other important medical events. No further info is available. A copy of the pt's medical record is available upon request.
Sex: F
Vaccine: HEP, MMR
Symptoms: Drug toxicity, Nervous system disorder
Clinical narrative: Information has been received regarding a case in litigation concerning a female child who, for the first two years of her life, was vaccinated with injections containing the "dangerous and highly toxic" mercury based preservative thimerosal. The alleged result of these vaccinations is that the pt now suffers from, and in the future will continue to suffer from, the toxic neurological effects of mercury poisoning. Immunization records were received as follow-up info. Per the records, on 08/06/97, the pt was vaccinated in the right thigh with varicella virus vaccine live (lot 05363 reported, invalid for the product) and in the right thigh with MMR vaccine (lot 620805/0239E). Concomitant vaccinatiions included ActHib/DTP (lot 0776040 given IM in the left upper outer gluteal on 09/19/96; lot 0795420 given IM in the right upper outer gluteal on 11/20/96; lot 0795470 given IM in the left thigh on 01/22/97), Orimune (lot 0745K given on 09/19/96; lot 0744H given 11/20/96; lot 0749M given 01/22/97), hep b vaccine recomb (Engerix B unreported lot given 07/20/96; lot 2129A2 given IM in the right thigh on 09/19/96; lot 2201A2 given IM in the right thigh on 01/22/97) and PPD test (lot 250311) given in the right arm on 09/30/99. Upon internal review toxic neurological effect and mercury poisoning were determined to be other important medical events. No further info is available.  Reported on 03/14/2003: "This is an amended report.  The primary suspect therapy was changed from varicella virus vaccine live to hepatitis B vaccine recombinant (yeast)(manufacturer unknown).  This report was corrected as amended.  Reported on 05/14/2003: "Follow up information received on 05/01/2003 reported that the patient received injections of vaccines allegedly containing thimerosal on the following dates: 07/20/1996, 09/19/1996, 11/20/1996, 01/22/1997, 08/16/1997, 09/30/1999, and 11/23/1999.  Upon internal review toxic neurological effect and mercury poisoning were determined to be other important medical events.  No further information is available.
Age: 0.7
Sex: M
Vaccine: HEP
Symptoms: Drug toxicity, Nervous system disorder
Clinical narrative: Information has been received regarding a case in litigation concerning a male child who, for the first two years of his life, was vaccinated with injections containing the "dangerous and highly toxic" mercury based preservative thimerosal. The alleged result of these vaccinations is that the pt now suffers from, and in the future will continue to suffer from, the toxic neurological effects of mercury poisoning. Immunization records were received which stated that on 12/01/97, the pt was vaccinated in the right arm with hep b vaccine recombinant (lot 623673/0879E; lot numbers not reported for doses given on 02/16/97 and 06/23/98), MMR vaccine II live (lot 0834L given in the right thigh on 09/28/98), varicella virus vaccine live (lot not reported given on 12/07/97), IPOL (lot M1295 given in the left arm on 12/01/97; lot and manufacturer not reported for dose given on 02/16/98), Orimune (lot 0796T given on 0503/99), Tripedia (lot 7B91884 given in the left thigh on 12/01/97 and unreported site on 02/16/98; lot 01164W given in the left thigh on 04/20/98; lot not legible for dose given in the left arm on 05/03/99), ActHib (lot 78916D given in the right thigh on 12/01/97; lot and manufacturer not reported for dose given 02/16/98; lot 09274W given in the right thigh on 04/10/98) and PPD (lot not reported); result negative. No further info is available.  A 15-day follow up report received 05/20/2003 adds: Follow up info was received on 05/01/2003 that reported the pt received injections that were alleged to contain thimerosal on the following dates: 12/01/1997, 02/16/1998, 04/20/1998, 06/25/1998 (reported as 06/23/1998 on immunization records), 09/28/1998, 05/03/1999 and 12/07/1999. Upon internal review, toxic neurologic effect and mercury poisoning were considered other important medical events. No further info is available.
Age: 1.25
Sex: M
Vaccine: HEP
Symptoms: Drug toxicity, Nervous system disorder
Clinical narrative: Information has been received regarding a case in litigation concerning male child who, for the first two years of his life, was vaccinated with injections containing the dangerous and highly toxic mercury based preservative thimerosal. The alleged result of these vaccinations is that the patient now suffers from, and in the future will continue to suffer from, the toxic neurological effects of mercury poisoning. Immunization records have been received as follow up. It was reported that the patient was vaccinated with a first dose of hepatitis B vaccine recombinant (yeast) (lot #616324/0409D given in the rigth thigh on 8/30/96; dose two through four were given on 5/30/97 (lot # not reported), 9/12/97 (lot# 622792/0312E), and 12/29/97 (lot #624329/1225E) and a fifth dose of hepatitis B vaccine, recomb (ENGERIX-B)(lot#ENG2145A was given in the right thigh on 2/3/97). Concomitant vaccines included MMR (lot#619384/0104E given in the left thigh on 7/31/97); lot #624725/1305E given 4/20/98), varicella virus vaccine live (lot#624645/1330E given on 4/20/98), diphtheria toxoid (-) Haemophilus B conjugate vaccine (+) pertussis vaccine (+) tetanus toxoid (ACTHIB/DTP)(lot #6411095 given IM in the left thigh on 10/8/96; lot# 6L71162 given IM in the left thigh on 12/9/96; lot # 6L71162 given IM in the left thigh on 2/3/97), diphtheria toxoid (+) Haemophilus B conjugate vaccine (+) pertussis vaccine (+) tetanus toxoid (TRIHIBIT) lot #7B01925 given in the left thigh on 1/29/98), oral poliovirus vaccine (ORIMUNE)(lot #0749L given 10/8/96; lot #0750A given 12/9/96 and 2/3/97; lot # 0722H given 1/29/98) oral poliovirus vaccine, manufacturer not reported, (lot # not provided for dose given on 5/30/97; lot #0770E given 9/12/97; lot #0793C given 10/21/98), diphtheria toxoid/pertussis vaccine/teta, manufacturer not reported, (lot# not reported for dose given 5/30/97; lot #7B81602 given 8/6/97; lot # 7B91821 given 10/14/97; lot # 0930790 given 10/21/98), HIB conjugate vaccine, manufacturer not reported (lot # not provided for dose given on 5/30/97; lot #7B91619 given 8/6/97; lot #7091845 given 10/14/97; lot # 0947790 given 7/16/98, and tuberculin purified protein derivative (lot # not provided, skin tests started on 4/20/97 and 6/29/99; results were not provided). Upon internal review, toxic neurological effect and mercury poisoning were determined to be other important medical events. No further information is available. A 15-day follow up report received 05/20/2003 adds: Follow up info received on 05/01/2003 reported that the dates of injection of vaccines that have been alleged as containing thimerosal include: 08/30/1996, 10/08/1996, 12/09/1996, 02/03/1997, 07/31/1997 and 01/29/1998. Upon internal review, toxic neurologic effects and mercury poisoning were considered other important medical events. No further info is available.
Age: 0.3
Sex: M
Vaccine: HEP, HIBV, OPV
Symptoms: Drug toxicity, Nervous system disorder
Clinical narrative: Information has been received regarding a case in litigation concerning a male child who was injected with vaccinations containing the toxic mercury based preservative thimerosal. The alleged result of these vaccinations is that the patient suffered from and in the future will continue to suffer the toxic neurological effects of mercury poisoning. Immunization records were received as follow up which stated that on 7/11/96, the patient was vaccinated in the left leg with a second dose of hepatitis B vaccine recombinant 9 (yeast)(lot# 619088/0135D). The first and third doses of hepatitis B vaccine recombinant (Engerix-B) were given in the left leg on 4/4/96 (lot# 1967A2) and on 2/13/97 in the left thigh (lot # 2196A2). Concomitant therapy included MMR (lot # 1248D reported, invalid for the product) given on 3/10/97, SC, in the left thigh, diphtheria toxoid (+) Haemophilus B conjugate vaccine (+) pertussis vaccine (+) tetanus toxoid (ACTHIB/DTP)(lot# 5L6174 given in the left leg on 5/7/96; lot # 5F71109 given in the left leg on 7/11/96; lot # 6H71044 given in the left leg on 3/9/96; and a dose of haemophilus B conjugate vaccine (lot # 7J81539) given in the left thigh on 7/16/97, oral poliovirus vaccine (ORIMUNE) (lot# 738M2 given on 5/7/96; lot #742P0 given on 7/11/96; lot #440072 given on 8/10/97), and tuberculin purified protein derivative (PPD TINE TEST)(lot # 2431-12 given on 3/10/97 in the left forearm. Upon internal review, mercury poisoning and neurological disorders were considered to be other important medical events. No further information is available. A follow up report received 05/20/2003 adds: Follow up info received on 05/01/2003 indicated that the pt received injections of vaccines allegedly containig thimerosal on the following dates: 04/04/1996, 05/07/1996, 07/11/1996, 09/03/1996, 02/13/1997, 03/10/1997 and 07/16/1997. Upon internal review, mercury poisoning and neurological disorders were considered to be other important medical events. No further info is available.
Age: 38.0
Sex: M
Vaccine: HEP, HEPA, TYP, YF
Symptoms: Arthralgia, Asthenia, Hypoaesthesia, Tendonitis, Visual disturbance
Clinical narrative: 2/7/01 hep A+B #1, yellow fever, typhoid-numerous canker sores in mouth. 8/9/01 hep A+B #2-numbness in extremities, joint pain, fleatgas in vision al, weakness, tendon pain. The 60 day follow-up states same effects as repeated originally.
Age: 43.0
Sex: F
Vaccine: LYME
Symptoms: Arthralgia, Back pain, Fibromyalgia, Joint range of motion decreased, Neck pain
Clinical narrative: Shoulder pain, limited movement in all joints, back pain, neck pain. Have several diseases; doctors can not yet tell if from the vaccine. Per follow-up information: Have fibromyalgia, have joint pain all over, need surgery now. The 60 day follow-up states," I don't think I ever will."  Annual follow up on 07/31/2003: "Patient is unknown about the recovery of adverse events.  Patient still having a lot of problems."
Age: 43.0
Sex: F
Vaccine: LYME
Symptoms: Shoulder pain
Clinical narrative: Shoulder pain, limited movement in all joints, back pain, neck pain. Have several diseases; doctors can not yet tell if from the vaccine. Per follow-up information: Have fibromyalgia, have joint pain all over, need surgery now. The 60 day follow-up states," I don't think I ever will."  Annual follow up on 07/31/2003: "Patient is unknown about the recovery of adverse events.  Patient still having a lot of problems."
Age: 1.0
Sex: F
Vaccine: HIBV, MMR, PNC, VARCEL
Symptoms: Dyskinesia, Pyrexia
Clinical narrative: Mom reports that this child was with her father and developed a fever Friday night. Told her that took her to ER but labs found out that not. Temperature 103 at that time. Father took her home around 3:00 am. Mom reports that was ok when got out of bed and then noticed her jerking her head. Took her to rescue squad and transported to hospital via ambulance.
Age: 1.14
Sex: M
Vaccine: MMR, PNC, VARCEL
Symptoms: Convulsion, Otitis media, Pyrexia
Clinical narrative: 2 x seizures, father states axillary fever 103 degrees. 1st ED visit pm 6-12, 2nd ED visit mid day 6-13/ then admit hospital. Medical Records recived on 9/09/2002 states ear infection.
Age: 0.5
Sex: F
Vaccine: DTAP, HBHEPB
Symptoms: Dehydration, Diarrhoea, Ketoacidosis, Laboratory test abnormal, Pyrexia
Clinical narrative: Mother states child became ill with fever, vomiting and diarrhea post shot given. After 3 days went to doctor and child was placed in hospital for dehydration.  Also diagnosed with moderate ketoacidosis.
Age: 0.5
Sex: F
Vaccine: DTAP, HBHEPB
Symptoms: Vomiting
Clinical narrative: Mother states child became ill with fever, vomiting and diarrhea post shot given. After 3 days went to doctor and child was placed in hospital for dehydration.  Also diagnosed with moderate ketoacidosis.
Age: 1.3
Sex: M
Vaccine: DTAPH, PNC, VARCEL
Symptoms: Face oedema, Oedema peripheral
Clinical narrative: Swelling of face, especially peri-orbital area, hands, arms, legs. Irritability. Ephinephrine 0.15 ml and Dexamethasone 4mg.
Age: 0.2
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, PNC
Symptoms: Crying, Irritability
Clinical narrative: Extreme crying, irritability.
Age: 0.2
Sex: M
Vaccine: DTAP, HIBV, PNC
Symptoms: Crying, Injection site oedema, Injection site pain, Screaming
Clinical narrative: Increased crying with high pitched squeak 2 1/4 hours after vaccines were given and continued til Tyl was given five hours after vaccines were given. Local reaction left thigh pin, sl. swollen at both injection sites. Tender if touched area. Cried with right leg movement but no local reaction on rigth site. Required five doses of Tyl. throughout night.
Age: 0.2
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Crying, Screaming
Clinical narrative: "Non-stop crying" starting 1-2 hour post injection and lasting 3-4 hours.
Age: 0.3
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Irritability, Pyrexia
Clinical narrative: Pt presents to clinic with c/o fever of 104 degrees, increase fussiness and unconsolable for past 12 hrs. Pt received vaccines the day before. Sites of injections non-reddened, non-swollen. Diagnosis: Pertussis reaction. Tx: Rocephin 1 gm given IM.
Age: 0.2
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC
Symptoms: Crying, Injection site oedema
Clinical narrative: Unconsolable crying-stopped crying when held. Slight swelling at injection site (RAT) approx 2-2 1/2" diameter, slight swelling at site on RAT.
Age: 0.2
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, PNC
Symptoms: Injection site erythema, Injection site oedema, Injection site warmth
Clinical narrative: Leg that DTaP, HIB, IPV given became red and swollen, hot to touch from top of thigh to top of knee.
Age: 0.2
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Area of left leg knee to thigh red and swollen at DTaP, HIB, IPV site ice applied, Tylenol given.
Age: 1.25
Sex: F
Vaccine: DTAP, IPV
Symptoms: Agitation, Balance disorder
Clinical narrative: Cried for 45 minute and seemed to have decrease balance. Child totally normal ? when seen in office. No fever.
Age: 4.3
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site oedema
Clinical narrative: Localized swelling left thigh, DTaP site.
Sex: U
Vaccine: UNK
Symptoms: Herpes zoster, Infection
Clinical narrative: Many years after vaccine with no history of chicken pox illness,  pt developed classic appearing shingles at great toe. Confirmed by another physician, responded Acyclir.
Age: 0.3
Sex: M
Vaccine: DTAP, HIBV, IPV
Symptoms: Injection site erythema, Injection site induration, Rash papular
Clinical narrative: 4 month with history of diffuse papular rash over trunk approx 24 hrs after receiving vaccine. No fever, no other symptoms. Mom describes injection site was initially red and hard, that eventually resolved after 2 days.
Age: 4.08
Sex: F
Vaccine: DTAP, HEPA, IPV, MMR
Symptoms: Urticaria
Clinical narrative: Pt had urticaria from waist down 2 days post hep A, DTaP, IPV, and MMR. No local reaction.
Age: 2.4
Sex: F
Vaccine: HBHEPB, MMR, VARCEL
Symptoms: Injection site erythema, Injection site oedema, Screaming
Clinical narrative: Mother called stated child has been crying all night and that left leg is swollen above where she had her shot. Advised to bring child in today and use cool compress to left leg and give Tylenol. 06/13/02 pt returned and took a look at the left leg quarter size red spot noted. Pt told to soak and put warm compresses on leg and take Tylenol. Come back if gets worse.
Age: 32.0
Sex: F
Vaccine: TD
Symptoms: Injection site induration, Injection site oedema
Clinical narrative: Area around site very hard and swollen.
Age: 0.5
Sex: F
Vaccine: DTAP, HBHEPB, IPV
Symptoms: Injection site mass, Injection site warmth
Clinical narrative: Mother of baby in office 06/27/02 at 3:25pm c/o lump in baby's right thigh since receiving immunizations on 06/21/02. Nurse states she used 1 3cc 25GA syringe with needle; 7mm lump palpates right anterolateral thigh. No redness, no bruises, no sign of pain to baby when palpated; hot to touch, baby very playful.
Age: 0.2
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV
Symptoms: Decreased appetite, Irritability, Pyrexia
Clinical narrative: 06/25/02 T99.4-99.7. 06/26/02AM decrease in appetite, very fussy, not consolable. 06/27/02 above sx worsened-taken to hospital. 06/28/02 Asymptomatic
Age: 1.0
Sex: M
Vaccine: HIBV, MMR
Symptoms: Urticaria
Clinical narrative: Urticarial rash within one hour, no known reactions with egg or neomycin.
Age: 5.5
Sex: M
Vaccine: DTAP, MMR
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site induration, Pruritus
Clinical narrative: 3 x 4cm redness and induration around the site of DTaP injection c/o itching.
Age: 1.6
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: 7cmx7cm redness and swelling left thigh.
Age: 1.4
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema
Clinical narrative: Area erythema around injection site that measures 11cm x 8cm. No systemic symptoms.
Age: 5.0
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV
Symptoms: Rash
Clinical narrative: Received DTaP, IPV, hep B on 07/01/02. Noted bumps on 07/05/02 on entire body that started to spread and get larger. No fever reported. No other symptoms. Went to ER on 07/07/02 was given Benadryl.
Sex: M
Vaccine: DTAP, MMR
Symptoms: Feeling hot, Injection site erythema, Injection site oedema, Injection site pain, Injection site reaction
Clinical narrative: Pt presents to clinic with right leg swelling and redness. No fever noted, warm to touch. Pt received vaccines yesterday. Diagnosis: local reaction to DTaP, right leg. Tx: Augmentin x 10d. When awakened c/o right leg pain.
Age: 34.0
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Eye pain, Fatigue, Pyrexia, Rash macular
Clinical narrative: 07/01/02 102 degrees fever, macular rash to face, trunk, arms, pain with eye movement, fatigue, joint pain in hands and knees. All symptoms resolved by 07/06/02. Fever until 07/02/02. Rash until 07/05/02.
Sex: M
Vaccine: DTAP, VARCEL
Symptoms: Cellulitis, Injection site reaction
Clinical narrative: Cellulitis at vaccination site right arm.
Age: 14.0
Sex: M
Vaccine: TD
Symptoms: Abdominal pain upper, Headache, Pain
Clinical narrative: Pt c/o soreness in right arm pit area the following day post immunization. No redness at site or under arm pit, no "lumps felt in arm pit. The pain seems to be increasing, had HA yesterday but was controlled with Aspirin. No fever." Mother stated pt c/o stomachache post the immunization also.
Age: 5.08
Sex: M
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: 8mm red, hard spot at injection site on 06/27/02.
Age: 1.25
Sex: M
Vaccine: DTAP, IPV
Symptoms: Injection site erythema
Clinical narrative: Pt playing in floor after immunization. Developed whelp left arm surrounded by redness. Spider later killed in exam room.
Age: 4.4
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Irritability, Rash, Rash maculo-papular, Urticaria
Clinical narrative: Had immunization on 07/02/02 at 1:30pm. Mom noticed rash at 10pm, face, heck, stomach, legs. Fussy. At HD 10am 07/03/02 now has whelts red raised on lower legs.
Age: 11.0
Sex: M
Vaccine: HEP
Symptoms: Convulsion, Dyskinesia, Fall
Clinical narrative: Several hours after injection was walking in house, fell backward and to floor with jerking movements. Transported via ambulance to hospital and kept overnight. No s/s illness, fever or injury. 06*14 to have neurology consult. Mom reported that only lab that was abnormal was low magnesium. 06/17/02 p.c. to parent of pt, she states she took child to neurologist and he started tp on carbiatrol 200mg and is to take this x 3 years. Reports all test normal except low magnesium. She reports pt had seizure 3 or so hours post #2 HBV. Mother states child may had had seizure 1 x when in the 6th grade post playing basketball at school. States doctor will decide if child should get 3rd dose HBV. Will check back with parent post pt's next visit to neurologist on the 18th.
Age: 84.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site oedema, Injection site pain
Clinical narrative: Local swelling, erythema, tenderness at injection site (right arm).
Age: 5.25
Sex: F
Vaccine: DTAP
Symptoms: Abscess, Blister, Cellulitis, Injection site erythema, Injection site induration
Clinical narrative: Leg area of induration/erythema on left leg. Small cluster of vesicles in center of erythema. ? abscess/cellulitis vs. inset bite. Called office 07/07/02 by mom to report.